SK life science is a subsidiary of SK Biopharmaceuticals, focused on developing innovative, next-generation drugs. Both are a part of SK Group, a global conglomerate headquartered in Korea. We are proud to be the first Korea-based company to discover, develop and commercialize a molecule from inception through FDA approval without partnering or out-licensing. We have 29 years of experience in R&D and are dedicated to changing the status quo in CNS.